This study tests whether the antiviral drug ensitrelvir can help people with long COVID by targeting leftover virus in the body. About 40 adults with long COVID symptoms will receive either the drug or a placebo for 10 days. The main goal is to see if the drug improves physical h…
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated May 18, 2026 12:04 UTC